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Abstract
Background: Herpes simplex virus (HSV) has two types: HSV-1 and HSV-2. Both infect epithelial cells and establish
latent infections in neurons causing an infection that persists for life. Information on age- and gender-specific
seroprevalence of HSV-1 and HSV-2 is valuable for understanding HSV transmission dynamics and designing
population-based prevention and intervention programs for HSV. However, such information is not available for China.
Methods: Cryopreserved serum samples of all subjects aged 5 to 60 years from two randomly selected rural
villages in Zhejiang province in Eastern China who had participated in the China national seroepidemiological
survey of hepatitis B virus (HBV) infection conducted in 2006 were tested. Seroprevalence of HSV-1 and HSV-2
infections were determined by type-specific IgG antibody tests using an ELISA technique. Their 95% confidence
intervals adjusted for the sampling fraction were calculated according to the Clopper-Pearson method.
Results: A total of 2,141 residents participated in the survey, with a response rate of 82.3%. HSV-1 seroprevalence
was 92.0% overall, 89.1% for males and 94.2% for females. HSV-1 seroprevalence was 61.6% among children aged
5-9 years, 90.3% among 25-29 years, and nearly 100% among those aged > = 40 years. HSV-2 seroprevalence was
13.2% overall, 10.5% for males and 15.3% for females. No children aged 5-14 years were HSV-2 positive, and HSV-2
seroprevalence was 7.1% among 15-19 years and peaked at 24.3% among those aged 45-49 years. Neither HSV-1 nor
HSV-2 infections were significantly different by gender. About 11.8% of study subjects were co-infected with both
types of HSV. Among 549 participating couples, 8.6% were HSV-1 serodiscordant and 11.8% were HSV-2
serodiscordant. No one tested positive for HIV. The overall prevalence of HBsAg was 16.2%, 16.9% for males and
15.4% for females.
Conclusions: HSV-1 was highly prevalent among all rural residents aged between 5-60 years in Eastern China,
whereas HSV-2 was prevalent among sexually active people. HSV-1 and HSV-2 have different transmission modes
and dynamics. Future HSV prevention and control programs in China should be type specific.
Background
Herpes simplex virus (HSV) belongs to subfamily alpha
of herpesvirinae and has two types: HSV-1 and HSV-2.
Both infect epithelial cells and establish latent infections
in neurons, causing an infection that persists for life.
Although HSV-1 and HSV-2 infections are generally
asymptomatic, both viruses can cause a wide spectrum of
clinical manifestations. HSV-1 is classically associated
with oropharyngeal lesions transmitted horizontally in
childhood, causes recurrent attacks of “fever blisters”,
and has been shown to account for an increasing propor-
tion of primary genital herpes, especially in women [1]. It
is also the leading cause of sporadic encephalitis in the
United States and several other countries [2]. HSV-2 pri-
marily infects the genital mucosa and is the main cause
of genital herpes. HSV-2 infection is acquired primarily
through contact with infected genital secretions and this
strong association, provides a useful marker for sexual
behavior [3]. Further, it is widely implicated as an impor-
tant cofactor for HIV acquisition [4,5]. HSV-2 is one of
the most common causes of neonatal herpes and also can
cause encephalitis in the immunocompromised host [6].
Meanwhile, clinical manifestations of a chronic HSV
infection (HSV-1 or HSV-2) among HIV/AIDS patients
have been regarded by the World Health Organization
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progression of HIV/AIDS [7].
Both HSV-1 and HSV-2 infections are known to be
common throughout the world [8]. However, China cur-
rently has no estimates of the prevalence of HSV-1
infection and only limited estimates of HSV-2 infection
among selected subpopulations [9-16]. Additionally
there have been no studies that have ascertained age-
and gender-specific seroprevalence of HSV-1 and HSV-
2i nt h eg e n e r a lp o p u l a t i o ni nC h i n a .S u c hi n f o r m a t i o n
is valuable for understanding HSV transmission
dynamics and designing type-specific, population-based
prevention and intervention programs for HSV. To pro-
vide these estimates, we conducted a seroepidemiologic
survey of HSV among rural community residents in
Zhejiang province, Eastern China. Given the association
of HSV-2 infection with sexual behavior and HIV acqui-
sition, we also tested for HIV infection in this study.
Furthermore, since Hepatitis B virus (HBV) infection is
endemic in China and is also associated with sexual
contact and classified by WHO as a sexually transmitted
disease, we also reported the seroprevalence of HBV
infection among the study participants.
Methods
Study Sample
In 2006, the Chinese Center for Disease Control and
Prevention (Chinese CDC) organized and conducted a
national seroepidemiological survey of hepatitis B virus
(HBV) infection (China Ministry of Health, April 21,
2008). As part of this study, two out of seventy-two vil-
lages in the rural community of Zhejiang province in
Eastern China were randomly selected using a cluster
sampling strategy and all local permanent residents
between the ages of 5 to 60 years were recruited to par-
ticipate. Those 18 years or older provided consent for
themselves and parental consent was obtained for those
less than 18. The consent form clearly illustrated the
background, importance and significance of the study,
and documented that future use of stored blood samples
would be approved by the relevant Institutional Review
Board (IRB). The initial study was approved by the IRB
of the Chinese CDC. From these two villages, a total of
2,600 eligible residents were approached and 2,141
(82.3%) participated in the survey. Table 1 presents age-
and gender-specific participation rates. The overall parti-
cipation rate was not significantly different by gender
(Chi-squared test, c
2 =0 . 0 1 ;P = 0.911) but significantly
different by age groups (Chi-squared test, c
2 = 45.78;
P < 0.001). Venous blood was collected from all partici-
pants by professional nurses using disposable sterile
needles and tubes. The blood was centrifuged, and the
serum was frozen in 500-μL aliquots.
For the present secondary data analysis, the cryopre-
served serum samples from these participants were
tested to ascertain age- and gender-specific seropreva-
lence of HSV-1 and HSV-2 infections. The testing was
performed anonymously and the serological results of
HSV-1 and HSV-2 infections were not linked to the par-
ticipants. The protocol for the present serological study
was reviewed and approved by the Institutional Review
Board (IRB) of Fudan University, Shanghai, China.
Blood testing
HSV Antibody Testing: HSV type-specific IgG antibody
was tested using an enzyme-linked immunosorbent assay
(ELISA) technique (HerpeSelect 1 ELISA IgG Kit and
HerpeSelect 2 ELISA IgG Kit, Focus Technologies, CA,
USA). All tests were performed by two experienced tech-
nicians from the key laboratory of the leading institution,
according to the manufacturers’ standard protocols. Each
plate run included duplicate Cut-off Calibrators and four
controls including a High Positive Control, a Low Posi-
tive Control, a Negative Control and a Blank Control.
Results were reported as index values relative to the Cut-
off Calibrator. To calculate index values, specimen opti-
cal density (OD) values were divided by the mean of the
duplicate Cutoff Calibrator absorbance values. An index
value of >1.10 was reported as seropositive for HSV-1 or
HSV-2, and those with index values < 0.9 were recorded
as negative, and those with index values between 0.9 and
1.1 were recorded as equivocal and were retested. Those
retested and found to have index values >1.1 were
recorded as positives. Those samples in which results
remained equivocal were retested using another ELISA
technique (HerpeSelect 1 ELISA IgG Kit and HerpeSelect
2 ELISA IgG Kit, Euroimmun, Lübeck, Germany). Only
34 (1.6%) samples, 32 for HSV-1 and 2 for HSV-2 in this
study were recorded as equivocal on the first test but not
equivocal on re-testing. The results of the 34 samples
retested were all negative.
HIV and HBV testing
Anti-HIV IgG antibody and HBV surface antigen
(HBsAg) were tested using an ELISA technique (Wantai
Biological Pharmacy Enterprise Co., Beijing, China). All
tests were performed according to the manufacturer’s
standard protocols.
Data Analysis
Seroprevalence of HSV-1 and HSV-2 as well as their
95% confidence intervals (CIs) adjusted for the sampling
fraction were calculated and tabulated by stratifying on
age and gender, according to the Clopper-Pearson
method using the software package Stata 11.0 (Stata-
Corp, Texas, USA). Seroprevalence of HBsAg was also
calculated by age and gender.
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Page 2 of 6Table 1 Age- and gender-specific seroprevalence of HSV-1 and HSV-2 among rural residents in Eastern China
Male (n = 1065) Female (n = 1076) Total (n = 2141)
HSV-1 HSV-2 HSV-1 HSV-2 HSV-1 HSV-2
Age (years) Tested/Eligible %* %** (95% CI) %** (95% CI) Tested/Eligible %* %** (95% CI) %** (95% CI) Tested/Eligible %* %** (95% CI) %** (95% CI)
5- 75/106 70.8 59.8 (20.9-98.8) 0 40/54 74.1 64.9 (46.4-83.5) 0 115/160 71.9 61.6 (27.3-95.8) 0
10- 64/84 76.2 78.0 (47.6-100.0) 0 45/74 60.8 78.3 (37.8-100.0) 0 109/158 69.0 78.1 (75.2-81.1) 0
15- 89/109 81.7 76.5 (68.9-84.0) 5.4 (0-33.5) 78/97 80.4 87.5 (20.0-100.0) 8.9 (0-18.6) 167/206 81.1 81.6 (48.4-100.0) 7.1 (0-19.2)
20- 93/120 77.5 81.9 (43.2-100.0) 8.9 (0-64.1) 101/121 83.5 86.1 (64.5-100.0) 12.0 (0-48.7) 194/241 80.5 84.0 (78.0-90.0) 10.5 (0-54.5)
25- 112/134 83.6 86.5 (64.5-100.0) 5.3 (0-14.6) 135/155 87.1 93.3 (58.3-100.0) 13.3 (0-37.0) 247/289 85.5 90.3 (58.3-100.0) 9.7 (0-30.2)
30- 137/157 87.3 90.4 (72.2-100.0) 10.2 (2.4-18.0) 152/182 83.5 96.7 (94.7-100.0) 13.1 (5.0-21.3) 289/339 85.3 93.8 (82.3-100.0) 11.8 (11.5-12.0)
35- 144/163 88.3 93.7 (85.2-100.0) 13.8 (0-34.6) 154/182 84.6 95.5 (81.4-100.0) 16.2 (0-77.7) 298/345 86.4 94.6 (82.8-100.0) 15.1 (0-57.7)
40- 118129 91.5 97.4 (89.6-100.0) 13.6 (6.8-20.4) 129/153 84.3 98.4 (97.7-99.2) 17.8 (0-38.2) 247/282 87.6 98.0 (94.5-100.0) 15.9 (2.7-29.0)
45- 89/113 78.8 96.7 (60.5-100.0) 23.7 (0-100.0) 97/114 85.1 98.0 (76.9-100.0) 24.9 (0-60.5) 186/227 81.9 97.4 (68.7-100.0) 24.3 (0-84.8)
50- 82/106 77.4 98.7 (87.7-100.0) 8.5 (0-52.1) 101/120 84.2 98.1 (69.7-100.0) 16.1 (0-80.7) 183/226 81.0 98.4 (88.4-100.0) 12.5 (0.3-24.8)
55- 62/71 87.3 98.4 (76.2-100.0) 16.1 (4.7-37.0) 44/56 78.6 97.8 (71.8-100.0) 16.1 (0-63.0) 106/127 83.5 98.1 (97.1-99.1) 16.1 (7.1-25.2)
Total 1065/1292 82.4 89.1 (70.0-100.0) 10.5 (10.4-10.5) 1076/1308 82.3 94.2 (94.0-94.5) 15.3 (0-33.3) 2141/2600 82.3 92.0 (84.2-99.8) 13.2 (3.6-22.7)
*: participation rate; **: seroprevalence.
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HSV-1 Seroprevalence
As shown on Table 1, the overall HSV-1 seroprevalence
was 92.0% in the study sample, and was comparable by
sex, 89.1% for males and 94.2% for females (Figure 1).
High levels of HSV-1 infection were found very early in
childhood, with a seropositivity of 61.6% among children
aged 5-9 years. HSV-1 seroprevalence increased to
90.3% among those aged 25 to 29 years and gradually
increased up to nearly 100% among those aged over
40 years.
HSV-2 Seroprevalence
The overall HSV-2 seroprevalence was 13.2%, and was
also comparable between males and females at each age
group, 10.5% for males and 15.3% for females (Table 1
and Figure 1). No participants 5 to 14 year old in this
sample were infected with HSV-2. HSV-2 seropreva-
lence was first detected among the 15 to 19 year old age
group (7.1%) and then gradually rose to a rate of 24.3%
among those aged at 45 to 49.
HSV-1 and HSV-2 Co-infections
Approximately 11.8% (252/2,141) of participants were
co-infected with both types of HSV. Co-infections were
more common among females (13.6%) than males
(10.0%). There were a total of 549 participating couples.
The mean age was 40.14 years (standard deviation: 9.77)
and the median age was 39.37 for husbands. The mean
age was 37.82 years (standard deviation: 9.30) and the
median age was 36.95 for wives. Among these couples,
498 couples (90.7%) were seroconcordant HSV-1 posi-
tives, 47 couples (8.6%) were HSV-1 serodiscordant and
only 4 couples (0.7%) were seroconcordant HSV-1
negatives; whereas 44 couples (8.0%) were seroconcor-
dant HSV-2 positives, 65 couples (11.8%) were HSV-2
serodiscordant and 440 couples (80.1%) were serocon-
cordant HSV-2 negatives.
HIV and HBsAg seroprevalence
No one tested positive for HIV. The overall prevalence
of HBsAg was 16.2%, 16.9% for males and 15.4% for
f e m a l e s .T h ea g e - s p e c i f i cp r e v a l e n c eo fH B s A ga m o n g
males was 5.3%, 6.4%, 14.6%, 14.0%, 19.8%, 16.8%,
17.6%, 27.1%, 16.3%, 17.3%, 23.3%, respectively, with age
groups corresponding to the eleven five-year categories
shown in Table 1 (data not shown). Similarly, the age-
specific prevalence of HBsAg among females was 5.0%,
6.7%, 14.3%, 13.9%, 12.5%, 15.1%, 20.0%, 20.9%, 15.5%,
11.8%, 21.7%, respectively, for the same eleven age
groups (data not shown).
Discussion
To our knowledge, this is the first study to document
age- and gender-specific seroprevalence of both types of
H S Vi nag e n e r a lp o p u l a t i o ns a m p l ei nC h i n a .W e
observed a very high level of HSV-1 infection (92.0%)
and a relatively low level of HSV-2 infection (13.2%).
These observations are consistent with those in other
countries [8], but are significant, as HSV-1 prevalence
has never been reported in China. Limited studies con-
ducted in China have demonstrated HSV-2 prevalence as
high as 70% among female sex workers and as low as 5%
among general male rural migrants [10,13-15], with rates
typically higher in women than men. Our gender-specific
HSV-2 prevalence was 10.5% for males and 15.3% for
females and was found to be higher than that among
market vendors (6.4% for males and 12.0% for females) in
Fuzhou, the capital city of Fujian province and among
male migrants in Shanghai (5.5%) [9,10,15]. Such differ-
ences might be due to differences in the characteristics of
the study subjects. For instance, the participants in the
present study were local permanent residents while those
in the referred two studies were rural-to-urban migrants,
with possible greater opportunity for infection.
Differences in the age distributions between HSV-1 and
HSV-2 infections in the present study provide evidence
to the supposition that HSV-1 and HSV-2 have different
transmission modes and dynamics [17,18]. While HSV-1
is highly epidemic and ubiquitous for all age groups,
HSV-2 infection is most likely to occur among sexually
active people. Our findings suggest that future HSV
prevention and intervention programs should be type-
specific. Meanwhile, we found that a substantially higher
proportion of couple participants were seroconcordant
HSV-1 positive (90.7%) versus HSV-1 serodiscordant
(8.6%) than seroconcordant HSV-2 positive (8.0%) versus
HSV-2 serodiscordant (11.6%). These findings have two
Figure 1 Age- and gender-specific seroprevalence of HSV-1
and HSV-2 among rural residents in Eastern China.
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to be very high among the general adult population.
Therefore, the low proportion of HSV-1 serodiscordance
among couples might be due to the low prevalence of
HSV-1 negative; Second, HSV-1 can be transmitted by
both sexual and nonsexual contacts whereas HSV-2 is
almost always transmitted by sexual contacts. Therefore,
HSV-1 transmission between couples is more likely to
occur than HSV-2. Given that HSV-2 is predominantly
sexually transmitted and most couples in China do not
use condoms for marital sex [19], marital HSV-2 trans-
m i s s i o nc o u l db eac o n c e r nf o rf u t u r eS T Ip r e v e n t i o n
and control programs in Eastern China.
The limitations of the serological tests for HSV-1 and
HSV-2 should be noted. In this study, Focus Diagnostics
ELISAs were used for HSV-1 and HSV-2 serum antibody
detection in order to determine cumulative lifetime expo-
sure to infection. Previous validation studies have shown
high sensitivity but relatively poorer specificity for HSV-1
and HSV-2 Focus Diagnostics ELISAs using index values
of 1.10 when compared to the golden standard HSV
western blot [20,21]. This relatively poor specificity could
yield false positives, which might have leaded to an overes-
timation of the prevalence of HSV-1 and HSV-2 [20,21].
However, this study was based on a large sample size, thus
the age- and gender-specific prevalence patterns for
HSV-1 and for HSV-2 should be negligibly affected.
In addition, no one in the present study was positive
for HIV, suggesting a low HIV epidemic at the popula-
tion level. On the other hand, HBV infection was still
prevalent in this population especially among those aged
over 15 years. As HBV infection could be sexually trans-
mitted and because both HIV and HBV have severe
health outcomes, they are not ignorable for any success-
ful STI prevention and intervention programs in these
communities.
Conclusions
HSV-1 infection is highly prevalent among all age
groups whereas HSV-2 infection is most likely to occur
among sexually active people in Eastern China. HSV-1
and HSV-2 have different transmission modes and
dynamics in the population, and need type specific pre-
vention and control programs.
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